News

Medicines Evaluation Board (MEB) to join VAC2VAC

MEB is a regulatory agency and an independent administrative body residing under the Government of the Netherlands.

VAC2VAC: Progress summary of first year

During the first year of the VAC2VAC project ample of process has been made.

TRANSVAC2: Funding for European vaccine research infrastructure

The European Commission (EC), in the context of the Horizon 2020 Framework Programme, commits significant funding to TRANSVAC2, a...

Role of vaccines in combating anti-microbial resistance

In a news piece published by Nature, findings are summarised that highlight the important role vaccines could play as a strategy to...

Current efforts in Zika vaccines presented at Zika Virus & other Mosquito-borne Viruses conference

Science for Preparedness and Response in the Mediterranean Region.

EDUFLUVAC workshop

Four years of European research on the development of universal influenza vaccines: what have we learnt, and how can we move forward?

Workshop on universal influenza vaccines

The workshop will be held in Brussels, Belgium on 12-14 June 2017.

World Malaria Day 2017: End Malaria For Good

World Malaria Day is a chance to shine a spotlight on the global effort to control malaria.

"Immunoassay standardisation for universal influenza vaccines" report is now online.

The meeting report from the EDUFLUVAC workshop is now available.

A new paper related to the MVVC project has recently been published in Molecular Therapy

“Viral Vector Malaria Vaccines Induce High-Level T Cell and Antibody Responses in West African Children and Infants”

EVI welcomes a new member to the team

EVI extends a warm welcome to María del Mar Castro.

EURIPRED call for free services

EURIPRED facilitates and supports translational research for poverty related diseases, such as HIV, TB, malaria and hepatitis.

New publication related to MVVC

A new paper related to the MVVC project has recently been published in the PLoS One journal.